TABLE 2

Discriminative Measures: Pattern-Based Classification Versus Final Clinical Diagnosis

Symptom duration (y)
Discriminative measureAll patients (n = 129)≤2 (n = 77)>2 (n = 52)
IPD
 Sensitivity83% (67/81)90% (36/40)76% (31/41)
 Specificity94% (45/48)95% (35/37)91% (10/11)
 PPV96% (67/70)95% (36/38)97% (31/32)
 NPV76% (45/59)90% (35/39)50% (10/20)
APS
 Sensitivity63% (30/48)62% (23/37)64% (7/11)
 Specificity95% (77/81)98% (39/40)93% (38/41)
 PPV88% (30/34)96% (23/24)70% (7/10)
 NPV81% (77/95)74% (39/53)91% (38/42)
MSA
 Sensitivity79% (11/14)73% (8/11)
 Specificity90% (18/20)92% (12/13)
 PPV85% (11/13)89% (8/9)
 NPV86% (18/21)80% (12/15)
PSP
 Sensitivity100% (16/16)100% (12/12)
 Specificity94% (17/18)100% (12/12)
 PPV94% (16/17)100% (12/12)
 NPV100% (17/17)100% (12/12)
  • Data are % (no. of subjects).